Stockreport

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Mirum Pharmaceuticals MIRM announced that it has completed enrollment in the phase III EXPAND study, which evaluated Livmarli (maralixibat) for treating cholestatic pru [Read more]